Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
POLICY PAPERS
March 10, 2023
Rigorous, explicit, evidence-informed priority-setting (EIPS) in healthcare is an essential instrument for achieving value for money. Growing pressures on healthcare budgets, combined with the post-COVID-19 fiscal crises and plateauing development assistance for health, make institutionalising EIPS ...
Jan
11
2023
2:00—3:00 PM Eastern Time | 7:00 - 8:00pm GMT
December 21, 2022
The world economy has been suffering a series of destabilizing shocks. Consensus forecasts for global growth in 2023 have been downgraded significantly over the past six months. Although these forecasts do not point to a global recession for now, the steep slowdown heightens the likelihood of a glob...
Jan
12
2023
10:00—11:00 AM Eastern Time | 3:00—4:00 PM GMT
December 20, 2022
Please join us for a discussion with CGD President, Masood Ahmed and IFAD President, Alvaro Lario reflecting on his first 100 days in office. IFAD is the only multilateral institution focused exclusively improving the inclusivity, productivity, resilience, and sustainability of rural agriculture and...
Blog Post
December 15, 2022
Dr. Yi-Chun Lo of Taiwan’s Centers for Disease Control and National Taiwan University Hospital joins Javier Guzman to discuss Taiwan’s COVID-19 experience and broader pandemic preparedness and response efforts. Together, they discuss the lessons Taiwan learned from previous outbreaks like SARS, succ...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...